178 related articles for article (PubMed ID: 23614054)
41. Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Neuromuscul Disord; 2001 Mar; 11(2):192-6. PubMed ID: 11257477
[TBL] [Abstract][Full Text] [Related]
42. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
[TBL] [Abstract][Full Text] [Related]
43. Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats.
Daicho T; Yagi T; Takano S; Marunouchi T; Abe Y; Ohara M; Takeo S; Tanonaka K
Biol Pharm Bull; 2009 Aug; 32(8):1378-84. PubMed ID: 19652377
[TBL] [Abstract][Full Text] [Related]
44. Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia.
Graber TG; Rawls BL; Tian B; Durham WJ; Brightwell CR; Brasier AR; Rasmussen BB; Fry CS
Exp Gerontol; 2018 Jun; 106():88-100. PubMed ID: 29452288
[TBL] [Abstract][Full Text] [Related]
45. S-Nitroso-L-Cysteine Ameliorated Pulmonary Hypertension in the MCT-Induced Rats through Anti-ROS and Anti-Inflammatory Pathways.
Wang M; Luo P; Shi W; Guo J; Huo S; Yan D; Peng L; Zhang C; Lv J; Lin L; Li S
Oxid Med Cell Longev; 2021; 2021():6621232. PubMed ID: 33574976
[TBL] [Abstract][Full Text] [Related]
46. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
Hacker AD
Biochem Pharmacol; 1993 Jun; 45(12):2475-81. PubMed ID: 8328985
[TBL] [Abstract][Full Text] [Related]
47. Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.
Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Cheng Y; Goldberg L; Ventetuolo CE; Liang O; Klinger JR; Quesenberry PJ
Stem Cells Transl Med; 2017 Jul; 6(7):1595-1606. PubMed ID: 28474513
[TBL] [Abstract][Full Text] [Related]
48. Contractile properties and histochemical characteristics of the rat diaphragm after prolonged triamcinolone treatment and nutritional deprivation.
Koerts-De Lang E; Schols AM; Wouters EF; Gayan-Ramirez G; Decramer M
J Muscle Res Cell Motil; 1998 Jun; 19(5):549-55. PubMed ID: 9682141
[TBL] [Abstract][Full Text] [Related]
49. Detrimental effects of short-term glucocorticoid use on the rat diaphragm.
Eason JM; Dodd SL; Powers SK; Martin AD
Phys Ther; 2000 Feb; 80(2):160-7. PubMed ID: 10654062
[TBL] [Abstract][Full Text] [Related]
50. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.
Kögler H; Hartmann O; Leineweber K; Nguyen van P; Schott P; Brodde OE; Hasenfuss G
Circ Res; 2003 Aug; 93(3):230-7. PubMed ID: 12842921
[TBL] [Abstract][Full Text] [Related]
51. Rapid onset of specific diaphragm weakness in a healthy murine model of ventilator-induced diaphragmatic dysfunction.
Mrozek S; Jung B; Petrof BJ; Pauly M; Roberge S; Lacampagne A; Cassan C; Thireau J; Molinari N; Futier E; Scheuermann V; Constantin JM; Matecki S; Jaber S
Anesthesiology; 2012 Sep; 117(3):560-7. PubMed ID: 22766523
[TBL] [Abstract][Full Text] [Related]
52. Corticosteroid effects on isotonic contractile properties of rat diaphragm muscle.
Van Balkom RH; Zhan WZ; Prakash YS; Dekhuijzen PN; Sieck GC
J Appl Physiol (1985); 1997 Oct; 83(4):1062-7. PubMed ID: 9338411
[TBL] [Abstract][Full Text] [Related]
53. Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension.
Sirmagul B; Ilgin S; Atli O; Usanmaz SE; Demirel-Yilmaz E
Clin Exp Hypertens; 2013; 35(3):220-7. PubMed ID: 22967272
[TBL] [Abstract][Full Text] [Related]
54. Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Yip HK
Circ J; 2008 May; 72(5):825-31. PubMed ID: 18441466
[TBL] [Abstract][Full Text] [Related]
55. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.
Lourenço AP; Roncon-Albuquerque R; Brás-Silva C; Faria B; Wieland J; Henriques-Coelho T; Correia-Pinto J; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1587-94. PubMed ID: 16679394
[TBL] [Abstract][Full Text] [Related]
56. Exercise Training Prevents Diaphragm Contractile Dysfunction in Heart Failure.
Mangner N; Bowen TS; Werner S; Fischer T; Kullnick Y; Oberbach A; Linke A; Steil L; Schuler G; Adams V
Med Sci Sports Exerc; 2016 Nov; 48(11):2118-2124. PubMed ID: 27327028
[TBL] [Abstract][Full Text] [Related]
57. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
58. The effect of obesity on the contractile performance of isolated mouse soleus, EDL, and diaphragm muscles.
Tallis J; Hill C; James RS; Cox VM; Seebacher F
J Appl Physiol (1985); 2017 Jan; 122(1):170-181. PubMed ID: 27856719
[TBL] [Abstract][Full Text] [Related]
59. Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension.
Chen MJ; Chiang LY; Lai YL
Toxicol Appl Pharmacol; 2001 Mar; 171(3):165-73. PubMed ID: 11243916
[TBL] [Abstract][Full Text] [Related]
60. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
Okada M; Harada T; Kikuzuki R; Yamawaki H; Hara Y
J Pharmacol Sci; 2009 Oct; 111(2):193-200. PubMed ID: 19809219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
